DK1689775T3 - GAG-bindende proteiner - Google Patents

GAG-bindende proteiner

Info

Publication number: DK1689775T3
Authority: DK; Denmark
Prior art keywords: gag; binding proteins; proteins; binding
Prior art date: 2003-12-04

Application number

DK04801190.2T

Other languages

English (en)

Inventor

Andreas J Kungl

Original Assignee

Protaffin Biotechnologie Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-12-04

Filing date

2004-12-02

Publication date

2011-09-26

2004-12-02 Application filed by Protaffin Biotechnologie Ag filed Critical Protaffin Biotechnologie Ag

2011-09-26 Application granted granted Critical

2011-09-26 Publication of DK1689775T3 publication Critical patent/DK1689775T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
- C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5421—IL-8
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Toxicology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Neurosurgery (AREA)
Orthopedic Medicine & Surgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Pulmonology (AREA)
Immunology (AREA)
Hospice & Palliative Care (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Dermatology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK04801190.2T 2003-12-04 2004-12-02 GAG-bindende proteiner DK1689775T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
AT0195203A AT412785B (de)	2003-12-04	2003-12-04	Gag-bindungsproteine
PCT/EP2004/013670 WO2005054285A1 (en)	2003-12-04	2004-12-02	Gag binding proteins

Publications (1)

Publication Number	Publication Date
DK1689775T3 true DK1689775T3 (da)	2011-09-26

Family

ID=33494536

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK04801190.2T DK1689775T3 (da)	2003-12-04	2004-12-02	GAG-bindende proteiner
DK06117339T DK1752470T3 (da)	2003-12-04	2004-12-02	GAG-bindende proteiner

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK06117339T DK1752470T3 (da)	2003-12-04	2004-12-02	GAG-bindende proteiner

Country Status (20)

Country	Link
US (4)	US7585937B2 (da)
EP (5)	EP2311866A1 (da)
JP (3)	JP4980721B2 (da)
KR (2)	KR101188785B1 (da)
CN (1)	CN1890264B (da)
AT (3)	AT412785B (da)
AU (1)	AU2004295104B2 (da)
BR (1)	BRPI0416544A (da)
CA (1)	CA2546789A1 (da)
CY (2)	CY1109480T1 (da)
DE (1)	DE602004022595D1 (da)
DK (2)	DK1689775T3 (da)
ES (2)	ES2369139T3 (da)
IL (1)	IL175565A0 (da)
NZ (1)	NZ547612A (da)
PL (2)	PL1752470T3 (da)
PT (2)	PT1689775E (da)
SG (1)	SG149000A1 (da)
SI (2)	SI1752470T1 (da)
WO (1)	WO2005054285A1 (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AT412785B (de) *	2003-12-04	2005-07-25	Kungl Andreas J Dr	Gag-bindungsproteine
EP1937815B1 (en)	2005-09-13	2015-05-13	National Research Council of Canada	Methods and compositions for modulating tumor cell activity
CN100366637C (zh) *	2005-11-17	2008-02-06	中国人民解放军第四军医大学	人白细胞介素8拮抗蛋白及其制备方法
US9422356B2 (en) *	2006-01-31	2016-08-23	Republic Of Korea (Republic Of National Fisheries Research And Development Institute)	Artificial signal peptide for expressing an insoluble protein as a soluble active form
ES2397441T5 (es)	2006-02-13	2022-09-14	Daiichi Sankyo Co Ltd	Secuencias polinucleotídicas y polipeptídicas implicadas en el proceso de remodelación ósea
US8168181B2 (en)	2006-02-13	2012-05-01	Alethia Biotherapeutics, Inc.	Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
EP1894571A1 (en) *	2006-08-29	2008-03-05	Protaffin Biotechnologie AG	Use of modified interleukin-8 proteins for treating reperfusion injury or transplant rejection
WO2008140500A2 (en) *	2006-12-08	2008-11-20	The University Of Miami	Hyaluronidase inhibitors as anti-cancer agents
AT504685B1 (de) *	2006-12-20	2009-01-15	Protaffin Biotechnologie Ag	Fusionsproteine
BRPI0811293A2 (pt) *	2007-05-07	2017-05-16	Peptimmune Inc	métodos para a expansão direta de epítopos para uso com ligantes de anticorpo.
EP2042516A1 (en)	2007-09-27	2009-04-01	Protaffin Biotechnologie AG	Glycosaminoglycan-antagonising MCP-1 mutants and methods of using same
US8012474B2 (en)	2007-08-02	2011-09-06	Nov Immune S.A.	Anti-RANTES antibodies
EP2053060A1 (en) *	2007-10-24	2009-04-29	Protaffin Biotechnologie AG	SDF-1-based glyocosaminoglycan antagonists and methods of using same
WO2009099631A1 (en)	2008-02-08	2009-08-13	Miles Lindsey A	Novel plasminogen receptor, polypeptides & antibodies thereof
US20120046218A1 (en)	2009-01-30	2012-02-23	Protaffin Biotechnologie Ag	Glycosaminoglycan-antagonising mcp-i mutants and methods of using same
AU2010294225A1 (en)	2009-09-11	2012-04-05	Protaffin Biotechnologie Ag	Composition for treatment of CXCL8-mediated lung inflammation
DK2504363T3 (da)	2009-11-24	2019-07-29	Alethia Biotherapeutics Inc	Anti-clusterin-antistoffer og antigenbindende fragmenter og deres anvendelse til reducering af tumorvolumen
GB201012603D0 (en) *	2010-07-27	2010-09-08	Ucb Pharma Sa	Protein purification
US20140073557A1 (en)	2011-03-16	2014-03-13	Protaffin Biotechnologie Ag	Fgfri-based antagonists with improved glycosaminoglycan affinity and methods of using same
EP2729487A2 (en)	2011-07-08	2014-05-14	Protaffin Biotechnologie AG	Novel sdf-1-based glycosaminoglycan antagonist and methods of using same
BR112014020756A2 (pt)	2012-02-22	2017-07-04	Alethia Biotherapeutics Inc	co-uso de um inibidor da clusterina com um inibidor do egfr para tratar o câncer
WO2014012165A1 (en)	2012-07-19	2014-01-23	Alethia Biotherapeutics Inc.	Anti-siglec-15 antibodies
WO2014079957A1 (de) *	2012-11-23	2014-05-30	Bayer Cropscience Ag	Selektive inhibition der ethylensignaltransduktion
US9493528B2 (en) *	2013-01-10	2016-11-15	Supadelixir Inc.	Microphthalmia-associated transcription factor-derived peptide and composition containing same
WO2015110526A1 (en) *	2014-01-22	2015-07-30	Antagonis Biotherapeutics Gmbh	Novel glycosaminoglycan-antagonising fusion proteins and methods of using same
US20220281934A1 (en)	2019-08-29	2022-09-08	Antagonis Biotherapeutics Gmbh	T-cell mobilizing cxcl10 mutant with increased glycosaminoglycan binding affinity
CN110791523B (zh) *	2019-12-13	2022-05-10	南京农业大学	一种棉花抗旱相关基因GhRCHY1及其应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4960691A (en) *	1986-09-29	1990-10-02	Abbott Laboratories	Chromatographic test strip for determining ligands or receptors
US5234911A (en) *	1990-07-09	1993-08-10	Gist-Brocades, N.V.	Substance with interleukin-8 inhibiting activity and process for its preparation
WO1992007935A1 (en) *	1990-11-01	1992-05-14	The Scripps Research Institute	Glycosaminoglycan-targeted fusion proteins, their design, construction and compositions
DE59407415D1 (de) *	1993-01-08	1999-01-21	Hoechst Ag	Verwendung von Leflunomid zur Hemmung von Interleukin 8
JP2694321B2 (ja) *	1993-03-10	1997-12-24	大塚製薬株式会社	インターロイキン−１阻害剤
US5527546A (en) *	1994-08-10	1996-06-18	Bayer Corporation	Human interleukin 6 inhibitor
US5866402A (en) *	1995-05-05	1999-02-02	Chiron Corporation	Chimeric MCP and DAF proteins with cell surface localizing domain
JPH1045602A (ja) *	1996-07-31	1998-02-17	Motoyasu Murakami	ヘリコバクター・ピロリ接着阻害剤またはインターロイキン−８産生阻害剤
US6852696B2 (en) *	1999-03-26	2005-02-08	The University Of Texas System	Inhibitors of glycosaminoglycans
EP1581615B1 (en) *	2000-09-05	2010-04-28	Biosight Ltd	Peptide conjugated anti-cancer prodrugs
UA77950C2 (en) *	2000-10-04	2007-02-15	Applied Research Systems	Use of mutants of cc chemokines for treatment of multiple sclerosis
GB0110430D0 (en) *	2001-04-27	2001-06-20	Medical Res Council	Protein variants and uses thereof
JP2003063980A (ja) *	2001-08-28	2003-03-05	Noevir Co Ltd	Ｒａｎｔｅｓ産生阻害剤
US6982170B1 (en) *	2001-12-17	2006-01-03	Maine Medical Center Research Institute	Compositions, methods and kits relating to thrombin degradation resistant fibroblast growth factor-1
JP2003306438A (ja) *	2002-02-18	2003-10-28	Shiseido Co Ltd	ケモカイン発現阻害剤
JP2003267887A (ja) *	2002-03-15	2003-09-25	Shiseido Co Ltd	ケモカイン発現抑制皮膚外用剤
IL164376A0 (en) *	2002-04-03	2005-12-18	Applied Research Systems	Ox4or binding agents, their preparation and pharmaceutical compositions containing them
BR0309238A (pt) *	2002-04-10	2005-02-15	Applied Research Systems	Antagonistas de proteìnas mcp
AT412785B (de) *	2003-12-04	2005-07-25	Kungl Andreas J Dr	Gag-bindungsproteine

2003
- 2003-12-04 AT AT0195203A patent/AT412785B/de not_active IP Right Cessation
2004
- 2004-12-02 EP EP10180909A patent/EP2311866A1/en not_active Withdrawn
- 2004-12-02 PL PL06117339T patent/PL1752470T3/pl unknown
- 2004-12-02 ES ES04801190T patent/ES2369139T3/es active Active
- 2004-12-02 CN CN200480036160.6A patent/CN1890264B/zh not_active Expired - Fee Related
- 2004-12-02 AU AU2004295104A patent/AU2004295104B2/en not_active Ceased
- 2004-12-02 CA CA002546789A patent/CA2546789A1/en not_active Abandoned
- 2004-12-02 EP EP10174625A patent/EP2363411A1/en not_active Withdrawn
- 2004-12-02 PT PT04801190T patent/PT1689775E/pt unknown
- 2004-12-02 PL PL04801190T patent/PL1689775T3/pl unknown
- 2004-12-02 NZ NZ547612A patent/NZ547612A/en not_active IP Right Cessation
- 2004-12-02 BR BRPI0416544-6A patent/BRPI0416544A/pt not_active IP Right Cessation
- 2004-12-02 SG SG200809009-4A patent/SG149000A1/en unknown
- 2004-12-02 KR KR1020067013411A patent/KR101188785B1/ko not_active IP Right Cessation
- 2004-12-02 EP EP10180974A patent/EP2270038A3/en not_active Withdrawn
- 2004-12-02 DE DE602004022595T patent/DE602004022595D1/de active Active
- 2004-12-02 EP EP06117339A patent/EP1752470B1/en not_active Not-in-force
- 2004-12-02 JP JP2006541888A patent/JP4980721B2/ja not_active Expired - Fee Related
- 2004-12-02 EP EP04801190A patent/EP1689775B1/en active Active
- 2004-12-02 AT AT06117339T patent/ATE439376T1/de active
- 2004-12-02 KR KR1020127011106A patent/KR101278459B1/ko not_active IP Right Cessation
- 2004-12-02 DK DK04801190.2T patent/DK1689775T3/da active
- 2004-12-02 AT AT04801190T patent/ATE515269T1/de active
- 2004-12-02 DK DK06117339T patent/DK1752470T3/da active
- 2004-12-02 WO PCT/EP2004/013670 patent/WO2005054285A1/en active Application Filing
- 2004-12-02 SI SI200431257T patent/SI1752470T1/sl unknown
- 2004-12-02 ES ES06117339T patent/ES2330362T3/es active Active
- 2004-12-02 SI SI200431747T patent/SI1689775T1/sl unknown
- 2004-12-02 PT PT06117339T patent/PT1752470E/pt unknown
2006
- 2006-05-11 IL IL175565A patent/IL175565A0/en unknown
- 2006-06-05 US US11/422,169 patent/US7585937B2/en not_active Expired - Fee Related
2008
- 2008-06-02 US US12/131,311 patent/US7807413B2/en not_active Expired - Fee Related
2009
- 2009-05-07 US US12/437,121 patent/US20110144305A1/en not_active Abandoned
- 2009-10-08 CY CY20091101039T patent/CY1109480T1/el unknown
2010
- 2010-08-18 US US12/858,456 patent/US20100331237A1/en not_active Abandoned
2011
- 2011-09-16 CY CY20111100904T patent/CY1112330T1/el unknown
2012
- 2012-02-27 JP JP2012040123A patent/JP2012139226A/ja active Pending
- 2012-04-05 JP JP2012086483A patent/JP2012165747A/ja active Pending

Also Published As

Publication number	Publication date
KR20120063542A (ko)	2012-06-15
US7807413B2 (en)	2010-10-05
BRPI0416544A (pt)	2007-01-09
EP2270038A2 (en)	2011-01-05
EP1689775A1 (en)	2006-08-16
KR20070001917A (ko)	2007-01-04
US7585937B2 (en)	2009-09-08
KR101278459B1 (ko)	2013-07-01
DE602004022595D1 (de)	2009-09-24
EP2270038A3 (en)	2011-02-23
EP2363411A1 (en)	2011-09-07
CY1112330T1 (el)	2015-12-09
ES2330362T3 (es)	2009-12-09
DK1752470T3 (da)	2009-12-14
ATE439376T1 (de)	2009-08-15
SI1689775T1 (sl)	2011-11-30
NZ547612A (en)	2009-07-31
AT412785B (de)	2005-07-25
US20100331237A1 (en)	2010-12-30
PL1689775T3 (pl)	2011-12-30
SI1752470T1 (sl)	2009-12-31
ATE515269T1 (de)	2011-07-15
WO2005054285A1 (en)	2005-06-16
PT1752470E (pt)	2009-10-15
EP1752470A1 (en)	2007-02-14
JP2012165747A (ja)	2012-09-06
EP1689775B1 (en)	2011-07-06
SG149000A1 (en)	2009-01-29
US20110144305A1 (en)	2011-06-16
EP1752470B1 (en)	2009-08-12
IL175565A0 (en)	2006-09-05
CN1890264A (zh)	2007-01-03
CN1890264B (zh)	2014-01-22
JP4980721B2 (ja)	2012-07-18
EP2311866A1 (en)	2011-04-20
AU2004295104A1 (en)	2005-06-16
PT1689775E (pt)	2011-10-13
AU2004295104B2 (en)	2010-07-22
JP2007536906A (ja)	2007-12-20
CY1109480T1 (el)	2014-08-13
CA2546789A1 (en)	2005-06-16
ATA19522003A (de)	2004-12-15
ES2369139T3 (es)	2011-11-25
JP2012139226A (ja)	2012-07-26
US20090005541A1 (en)	2009-01-01
PL1752470T3 (pl)	2010-01-29
US20080112926A1 (en)	2008-05-15
KR101188785B1 (ko)	2012-10-16

Publication	Publication Date	Title
NO2017058I1 (no)	2017-11-10	HPV 58 L1 protein
DK1752470T3 (da)	2009-12-14	GAG-bindende proteiner
NO2017012I1 (no)	2017-04-05	HPV 45 L1 protein
NO2014013I2 (no)	2014-05-21	Linaclotide
ATE363383T1 (de)	2007-06-15	Schlingenware
DE50204020D1 (de)	2005-09-29	Mikrotom
DK1653844T3 (da)	2013-03-11	Prionspecifikke peptidreagenser
AT502792A5 (de)	2007-05-15	Düsenanpressvorrichtung
NO20034452L (no)	2003-12-04	Sykdoms-assosiert protein
DE112004000620D2 (de)	2005-12-22	Struktoguss
DE502004000672D1 (de)	2006-07-20	Pigmentpreparationen
PT1393641E (pt)	2006-09-29	Entretela fixante
DE502004001524D1 (de)	2006-11-02	Hydrolager
ATA662003A (de)	2005-11-15	Trink-mundstück
ATE446959T1 (de)	2009-11-15	Chromenonindole
DE502004001629D1 (de)	2006-11-16	Bremsenprüfstand
DE50200752D1 (de)	2004-09-09	Mikrotom
DE502004000518D1 (de)	2006-06-14	Mitgängergabelhubwagen
DK1625148T3 (da)	2013-01-14	Peptidkompleks
DE10394329D2 (de)	2006-10-05	Mäanderstent
ATE406350T1 (de)	2008-09-15	Prolinylarylacetamide
DE112004002227D2 (de)	2006-07-27	Nietverarbeitungsgerät
DE10329218B4 (de)	2007-05-16	Hotflue
DE112004001561D2 (de)	2006-06-01	Getriebene-Antreibseinheit
DE20317661U1 (de)	2005-03-24	Faltkleiderschrank